The effect of oxygen tension on the long-term osteogenic differentiation and MMP/TIMP expression of human mesenchymal stem cells

Cells Tissues Organs

Volumn 191, Issue 3, 2010, Pages 175-184

  Raheja, Leah F ^a   Genetos, Damian C ^a   Yellowley, Clare E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Matrix metalloproteinase; Mesenchymal stem cell; Osteoblastic differentiation; Oxygen

Indexed keywords

COLLAGENASE 3; GELATINASE A; MATRIX METALLOPROTEINASE; OXYGEN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; ALKALINE PHOSPHATASE; CALCIUM; GELATINASE B; OSTEOCALCIN; OSTEOPONTIN;

ANGIOGENESIS; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DNA MICROARRAY; EX VIVO STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MESENCHYMAL STEM CELL; OSTEOBLAST; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE ENGINEERING; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; TIME;

ALKALINE PHOSPHATASE; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MESENCHYMAL STEM CELLS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; OXYGEN; TIME FACTORS; TISSUE ENGINEERING; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 77952315694     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235679     Document Type: Article

References (46)

1. Ambalavanan, N., T. Nicola, P. Li, A. Bulger, J. Murphy-Ullrich, S. Oparil, Y.F. Chen (2008) Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions. Pediatr Res 63: 26-32.
2. Arnett, T.R., B. Henderson (1998) Methods in Bone Biology. London, Chapman & Hall, p 37.
3. Aubin, J.E., J.T. Triffitt (2002) Mesenchymal Stem Cells and Osteoblast Differentiation; in Bilezikian, J.P., L.G. Raisz, G.A. Rodan, (eds): Principles of Bone Biology. San Diego, Academic Press, vol 1, pp 59-81.
4. Brighton, C.T., A.G. Krebs (1972) Oxygen tension of healing fractures in the rabbit. J Bone Joint Surg Am 54: 323-332.
5. Canning, M.T., L.M. Postovit, S.H. Clarke, C.H. Graham (2001) Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells. Exp Cell Res 267: 88-94.
6. Derkx, P., A.L. Nigg, F.T. Bosman, D.H. Birkenhager-Frenkel, A.B. Houtsmuller, H.A. Pols, J.P. van Leeuwen (1998) Immunolocalization and quantification of noncollagenous bone matrix proteins in methylmethacrylate- embedded adult human bone in combination with histomorphometry. Bone 22: 367-373.
7. Dimitriou, R., E. Tsiridis, P.V. Giannoudis (2005) Current concepts of molecular aspects of bone healing. Injury 36: 1392-1404.
8. D'Ippolito, G., S. Diabira, G.A. Howard, B.A. Roos, P.C. Schiller (2006) Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 39: 513-522.
9. Fehrer, C., R. Brunauer, G. Laschober, H. Unterluggauer, S. Reitinger, F. Kloss, C. Gully, R. Gassner, G. Lepperdinger (2007) Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6: 745-757.
10. Feng, J.Q., L.M. Ward, S. Liu, Y. Lu, Y. Xie, B. Yuan, X. Yu, F. Rauch, S.I. Davis, S. Zhang, H. Rios, M.K. Drezner, L.D. Quarles, L.F. Bonewald, K.E. White (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38: 1310-1315.
11. Fingleton, B., W.C. Powell, H.C. Crawford, J.R. Couchman, L.M. Matrisian (2007) A rat monoclonal antibody that recognizes proand active MMP-7 indicates polarized expression in vivo. Hybridoma (Larchmt) 26: 22-27.
12. Gerstenfeld, L.C., D.M. Cullinane, G.L. Barnes, D.T. Graves, T.A. Einhorn (2003) Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88: 873-884.
13. Giannelli, G., C. Bergamini, F. Marinosci, E. Fransvea, M. Quaranta, L. Lupo, O. Schiraldi, S. Antonaci (2002) Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int J Cancer 97: 425-431.
14. Grayson, W.L., F. Zhao, R. Izadpanah, B. Bunnell, T. Ma (2006) Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol 207: 331-339.
15. Henle, P., G. Zimmermann, S. Weiss (2005) Matrix metalloproteinases and failed fracture healing. Bone 37: 791-798.
16. Heppenstall, R.B., G. Grislis, T.K. Hunt (1975) Tissue gas tensions and oxygen consumption in healing bone defects. Clin Orthop Relat Res 357-365.
17. Holliday, L.S., H.G. Welgus, C.J. Fliszar, G.M. Veith, J.J. Jeffrey, S.L. Gluck (1997) Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 272: 22053-22058.
18. Holmbeck, K., P. Bianco, I. Pidoux, S. Inoue, R. C. Billinghurst, W. Wu, K. Chrysovergis, S. Yamada, H. Birkedal-Hansen, A.R. Poole (2005) The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone. J Cell Sci 118: 147-156.
19. Inoue, K., Y. Mikuni-Takagaki, K. Oikawa, T. Itoh, M. Inada, T. Noguchi, J.S. Park, T. Onodera, S.M. Krane, M. Noda, S. Itohara (2006) A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism. J Biol Chem 281: 33814-33824.
20. Kosaki, N., H. Takaishi, S. Kamekura, T. Kimura, Y. Okada, L. Minqi, N. Amizuka, U.I. Chung, K. Nakamura, H. Kawaguchi, Y. Toyama, J. D'Armiento (2007) Impaired bone fracture healing in matrix metalloproteinase-13 deficient mice. Biochem Biophys Res Commun 354: 846-851.
21. Lane, N.E., W. Yao, M. Balooch, R.K. Nalla, G. Balooch, S. Habelitz, J.H. Kinney, L.F. Bonewald (2006) Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res 21: 466-476.
22. Lennon, D.P., J.M. Edmison, A.I. Caplan (2001) Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol 187: 345-355.
23. Malaval, L., D. Modrowski, A.K. Gupta, J.E. Aubin (1994) Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 158: 555-572.
24. Manolagas, S.C., R.S. Weinstein (1999) New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 14: 1061-1066.
25. Martignetti, J.A., A.A. Aqeel, W.A. Sewairi, C.E. Boumah, M. Kambouris, S.A. Mayouf, K.V. Sheth, W.A. Eid, O. Dowling, J. Harris, M.J. Glucksman, S. Bahabri, B.F. Meyer, R.J. Desnick (2001) Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 28: 261-265.
26. Mosig, R.A., O. Dowling, A. DiFeo, M.C. Ramirez, I.C. Parker, E. Abe, J. Diouri, A.A. Aqeel, J.D. Wylie, S.A. Oblander, J. Madri, P. Bianco, S.S. Apte, M. Zaidi, S.B. Doty, R.J. Majeska, M.B. Schaffler, J.A. Martignetti (2007) Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum Mol Genet 16: 1113-1123.
27. Nagase, H., R. Visse, G. Murphy (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562-573.
28. Ortega, N., D.J. Behonick, C. Colnot, D.N. Cooper, Z. Werb (2005) Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol Biol Cell 16: 3028-3039.
29. Osinsky, S.P., I.I. Ganusevich, L.N. Bubnovskaya, N.V. Valkovskaya, A.V. Kovelskaya, T.K. Sergienko, S.V. Zimina (2005) Hypoxia level and matrix metalloproteinases-2 and -9 activity in Lewis lung carcinoma: correlation with metastasis. Exp Oncol 27: 202-205.
30. Potier, E., E. Ferreira, R. Andriamanalijaona, J.P. Pujol, K. Oudina, D. Logeart-Avramoglou, H. Petite (2007) Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone 40: 1078-1087.
31. Puchtler, H., S.N. Meloan, M.S. Terry (1969) On the history and mechanism of alizarin and alizarin red S stains for calcium. J Histochem Cytochem 17: 110-124.
32. Ridgway, P.F., P. Ziprin, N. Alkhamesi, P.A. Paraskeva, D.H. Peck, A.W. Darzi (2005) Hypoxia augments gelatinase activity in a variety of adenocarcinomas in vitro. J Surg Res 124: 180-186.
33. Robling, A.G., A.B. Castillo, C.H. Turner (2006) Biomechanical and molecular regulation of bone remodeling. Annu Rev Biomed Eng 8: 455-498.
34. Saed, G.M., W. Zhang, M.P. Diamond (2000) Effect of hypoxia on stimulatory effect of TGFbeta 1 on MMP-2 and MMP-9 activities in mouse fibroblasts. J Soc Gynecol Investig 7: 348-354.
35. Salim, A., R.P. Nacamuli, E.F. Morgan, A.J. Giaccia, M.T. Longaker (2004) Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem 279: 40007-40016.
36. Seibel M.J.R.E., C.M. Gundberg, R. Hannon, H.A.P. Pols (2002) Biochemical Markers of Bone Metabolism; in Bilezikian, J.P., Raisz L.G., Rodan, G.A. (eds): Principles of Bone Biology. San Diego, Academic Press, vol 2, pp 1543-1571.
37. Silver, I.A. (1975) Measurement of pH and ionic composition of pericellular sites. Philos Trans R Soc Lond B Biol Sci 271: 261-272.
38. Stanford, C.M., P.A. Jacobson, E.D. Eanes, L.A. Lembke, R.J. Midura (1995) Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270: 9420-9428.
39. Teti, A., A. Zallone (2009) Do osteocytes contribute to bone mineral homeostasis? Osteocytic osteolysis revisited. Bone 44: 11-16.
40. Vanderkooi, J.M., M. Erecinska, I.A. Silver (1991) Oxygen in mammalian tissue: methods of measurement and affinities of various reactions. Am J Physiol 260: C1131-C1150.
41. Vaupel, P. (1990) Oxygenation of human tumors. Strahlenther Onkol 166: 377-386.
42. Visse, R., H. Nagase (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839.
43. Vizoso, F.J., L.O. Gonzalez, M.D. Corte, J.C. Rodriguez, J. Vazquez, M.L. Lamelas, S. Junquera, A.M. Merino, J.L. Garcia-Muniz (2007) Study of matrix metalloproteinases and their inhibitors in breast cancer. Br J Cancer 96: 903-911.
44. Weinstein, R.S., R.L. Jilka, A.M. Parfitt, S.C. Manolagas (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest 102: 274-282.
45. Whyte, M.P. (2002) Hypophosphatasia: Nature's Window on Alkaline Phosphatase Function in Man; in Bilezikian, J.P., L.G. Raisz, G.A. Rodan (eds): Principles of Bone Biology. San Diego, Academic Press, vol 2, pp 1229-1248.
46. Wurtz, S.O., A.S. Schrohl, N.M. Sorensen, U. Lademann, I.J. Christensen, H. Mouridsen, N. Brunner (2005) Tissue inhibitor of metalloproteinases-1 in breast cancer. Endocr Relat Cancer 12: 215-227.